武清区龙济医院治疗包皮包茎的费用-【武清龙济医院 】,武清龙济医院 ,武清龙济医院男科,武清区龙济治男科好不好,去天津市龙济泌尿怎么走,天津天津市武清区龙济医院男科电话,武清龙济前列腺如何治疗,武清区龙济男科地理位置

WASHINGTON, April 19 (Xinhua) -- The U.S. National Aeronautics and Space Administration (NASA) on Tuesday set April 29 as the launch date for Endeavour's final voyage.The date was announced Tuesday at the conclusion of a flight readiness review at Kennedy Space Center. During the meeting, senior NASA and contractor managers assessed the risks associated with the mission and determined the shuttle and station's equipment, support systems and personnel are ready.Liftoff time is 3:47 p.m. EDT (1947 GMT). It will be the 134th shuttle mission overall, the 25th for Endeavour and the 36th shuttle mission to the International Space Station.Endeavour will deliver to the station a 2-billion-dollar, multinational particle detector known as the Alpha Magnetic Spectrometer.Space shuttle Endeavour sits on launch pad 39A with the crew aboard minutes before mission managers scrubbed the launch again at Cape Canaveral, Florida, July 13, 2009.The spectrometer, also designated AMS-02, is a particle physics experiment module that is to be mounted on the station. It is designed to search for various types of unusual matter by measuring cosmic rays. Its experiments will help researchers study the formation of the Universe and search for evidence of dark matter and antimatter.Endeavour's two-week mission was led by Commander Mark Kelly. Other crew include Pilot Greg Johnson, NASA Mission Specialists Michael Fincke, Andrew Feustel and Greg Chamitoff and European Space Agency Mission Specialist Roberto Vittori. Astronauts are planning to step out on four spacewalks to do maintenance work and install new components.NASA's 30-year-old shuttle program is ending this year due to high operating costs. The Obama administration wants to spur private companies to get into the space taxi business, freeing NASA to focus on deep space exploration and new technology development.Shuttle Atlantis is set for its final journey into space at the end of June. Its return to earth will mark the official end of the U.S. space shuttle program. After that, the Russian space program' s Soyuz capsule will be the only method for transporting astronauts to and from the station.
BEIJING, March 8 (Xinhuanet) -- U.S. Food and Drug Administration (FDA) announced there was no new reason for safety concern in Pfizer Inc's Prevenar and Sanofi Aventis SA's ActHIBor vaccines, according to media reports Tuesday.Health agencies "have not detected new safety concerns or unusual reporting patterns" in the vaccines, which are used to prevent forms of meningitis and pneumonia, FDA spokeswoman Shelly Burgess said in an emailed statement.Health agencies in the United States will continue to monitor the vaccines for safety, the spokeswoman added.The Japanese health ministry had decided to suspend the vaccines after four unexplained deaths were reported. The causes of the deaths are still investigated, the Japanese ministry said in a release on its website.

BRASILIA, March 15 (Xinhua) -- A nationwide program aimed at providing internet access to 80 percent of the country's population by 2014 is forging ahead in Brazil, Communications Minister Paulo Bernardo said on Tuesday.The National Broadband Plan (PNBL), with participation of 13 ministries, is coordinated by Bernardo, who explained details about the project on Tuesday along with Joao Santana, president of Telebras, the state-owned enterprise responsible for managing the project.The authorities have criticized companies that offer internet service for failing to spread internet use in Brazil, offering an expensive service with prices amounting to about 50 U.S. dollars monthly, inaccessible to low-income families."We ended 2010 with 34 percent of Brazilian households with Internet access, and service is also very poor. Almost half of connections are of 256 mbps. We are out-of-date, with the aggravating circumstance that the connections are very expensive," Bernardo said.To speed up the process, the government started negotiating with concessionaire phone companies to improve the service quality and lower the price to about 30 reais (18 dollars), which would allow 80 percent of the population to access internet."During (former president) Lula da Silva's government, we developed a program to interconnect all schools with internet access, but we also want the private sector to do its share," he said.
WASHINGTON, March 4 (Xinhua) -- New data suggest that the epilepsy drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration (FDA) said Friday in a statement.Before prescribing topiramate, approved to treat certain types of seizures in people who have epilepsy, health care professionals should warn patients of childbearing age about the potential hazard to the fetus if a woman becomes pregnant while using the drug, the FDA said.Topiramate also is approved to prevent migraine headaches, but not to relieve the pain of migraines."Health care professionals should carefully consider the benefits and risks of topiramate when prescribing it to women of childbearing age," said Russell Katz, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research. "Alternative medications that have a lower risk of birth defects should be considered."Cleft lip and cleft palate, collectively called oral clefts, are birth defects that occur when parts of the lip or palate do not completely fuse together early in the first trimester of pregnancy, a time when many women do not know they are pregnant.The defects range from a small notch in the lip to a groove that runs into the roof of the mouth and nose, possibly leading to problems with eating, talking, and to ear infections. Surgery often is performed to close the lip and palate and most children do well after treatment.Data from the North American Antiepileptic Drug (AED) Pregnancy Registry indicate an increased risk of oral clefts in infants exposed to topiramate during the first trimester of pregnancy. Infants exposed to topiramate as a single therapy experienced a 1.4 percent prevalence of oral clefts, compared with a prevalence of 0.38 percent - 0.55 percent in infants exposed to other antiepileptic drugs.Infants of mothers who did not have epilepsy and were not being treated with other antiepileptic drugs had a prevalence of 0.07 percent. Similar data from the United Kingdom Epilepsy and Pregnancy Register supported the North American AED Pregnancy Registry data.According to the FDA, before starting topiramate, pregnant women and women of childbearing potential should discuss other treatment options with their health care professional.
BEIJING, Feb.14 (Xinhua) - Shanghai General Motors Co. will recall 2,806 imported Cadillac CTS vehicles in China to repair faulty track bars to prevent safety risks, China's quality watchdog said on Monday.The recall, which is set to begin on March 21, includes models that were produced between June 16, 2008 and April 20, 2009, the General Administration of Quality Supervision, Inspection and Quarantine said in a statement on its website.The statement said that the company would repair or replace the rear suspension track bars of the recalled vehicles because some nuts on the bars are likely to loosen and cause worn screw threads.This could lead to a loosened track bar under extreme conditions, which is unsafe when traveling fast, it said.The company is to contact car owners to provide free checks and repairs. Owners may also contact the automaker on its free phone service (telephone number: 8008201902) for more information and to make appointments.
来源:资阳报